Study tests nerve side effects from certain chemotherapy drugs
Part of Brain & nervous system, Cancer, Pain clinical trials.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to start chemotherapy drugs that can potentially harm nerves (a specific list is used by the study).
- You are 18 years or older and can sign a consent form before joining.
- Your health is stable enough that you can likely complete the planned chemotherapy and all follow-up visits.
- You should not have brain or spinal nerve problems like brain tumors or metastases that would interfere with testing.
- You should not be on long-term nerve-affecting medicines (such as seizure medicines, antidepressants, or strong pain medicines) unless your dose has been stable for 3 months; also avoid other drugs known to harm peripheral nerves.
- You should not have had neurotoxic chemotherapy before, and you should not have severe depression that could affect testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tiny particles in your blood to understand and potentially predict nerve damage caused by certain chemotherapy drugs. Researchers will monitor you before, during, and after your cancer treatment to see if these particles can help warn doctors about this common side effect.
This trial tests whether spinal cord stimulation can reduce pain and improve quality of life in people with long-lasting nerve pain from chemotherapy (CIPN). You must already have tried at least two nerve-pain medicines and still have significant pain, and you must have had a successful spinal cord stimulator test before joining.
This study tests whether remote check-ins (via phone/app/website) can help manage chemotherapy-related nerve pain in the hands and feet. It enrolls adults who developed nerve symptoms after certain cancer medicines and need ongoing monitoring.
This study looks at nerve damage (neuropathy) that can happen as a side effect of chemotherapy. It aims to understand how common it is and how it affects people being treated for solid tumors.
This study looks at “TRP channels,” which are part of how nerves sense pain and temperature, to understand nerve pain (neuropathy) after chemotherapy. It may help improve how future treatments prevent or reduce nerve pain in people who have had certain chemotherapy drugs.
This study looks at how certain chemotherapy drugs affect the brain and cause nerve damage (peripheral neuropathy) in people with breast cancer. The goal is to find ways to prevent or reduce these side effects so that treatment can be more comfortable and effective.
Hear when a new Chemotherapy-induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.